Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 127, 2021 - Issue 6
196
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Artemisia herba-alba aqueous extract improves insulin sensitivity and hepatic steatosis in rodent model of fructose-induced metabolic syndrome

ORCID Icon, , , , , , , , & show all
Pages 541-550 | Received 18 Feb 2019, Accepted 19 Aug 2019, Published online: 29 Aug 2019

References

  • Aebi, H., 1974. Catalase. In: H.U. Bergmeyer, ed. Methods of enzymatic analysis, vol. 2, 2nd ed. New York: Academic Press, 673–684.
  • Aguilera-Mendez, A., et al., 2018. Protective effect of supplementation with biotin against high-fructose-induced metabolic syndrome in rats. Nutrition research, 57, 86–96.
  • Akar, F., et al., 2012. High-fructose corn syrup causes vascular dysfunction associated with metabolic disturbance in rats: protective effect of resveratrol. Food and chemical toxicology, 50(6), 2135–2141.
  • Al-Khazraji, S.M., et al., 1993. Hypoglycaemic effect of Artemisia herba alba. I. Effect of different parts and influence of the solvent on hypoglycaemic activity. Journal of ethnopharmacology, 40(3), 163–166.
  • Al-Shamaony, L., et al., 1994. Hypoglycaemic effect of Artemisia herba alba. II. Effect of a valuable extract on some blood parameters in diabetic animals. Journal of ethnopharmacology, 43(3), 167–171.
  • Al-Waili, N.S., 1988. Artemisia herba-alba Asso. in diabetes mellitus. Clinical and experimental pharmacology and physiology, 15(6), 497.
  • Allain, C.C., et al., 1974. Enzymatic determination of total serum cholesterol. Clinical chemistry, 20(4), 470–475.
  • Alwahsh, S.M., and Gebhardt, R., 2017. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). Archives of toxicology, 91(4), 1545–1563.
  • Andrade, N., et al., 2019. Chronic consumption of the dietary polyphenol chrysin attenuates metabolic disease in fructose-fed rats. European journal of nutrition. doi:https://doi.org/10.1007/s00394-019-01895-9
  • Aydin, S., et al., 2014. Today’s and yesterday’s of pathophysiology: biochemistry of metabolic syndrome and animal models. Nutrition, 30(1), 1–9.
  • Ben Abid, Z., et al., 2007. Artemisia herba-alba Asso (Asteraceae) has equivalent effects to green and black tea decoctions on antioxidant processes and some metabolic parameters in rats. Annals of nutrition and metabolism, 51(3), 216–222.
  • Ben Jemaa, H., et al., 2015. Antidiabetic, antihyperlipidemic and antioxidant effects of artemisia herba alba extract on experimental diabetes. International journal of pharmacology, 11(6), 552–560.
  • Bettaieb, A., et al., 2014. (–)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free radical biology and medicine, 72, 247–256.
  • Boudjelal, A., et al., 2015. Antidiabetic effects of aqueous infusions of Artemisia herba-alba and Ajuga iva in alloxan-induced diabetic rats. Planta medica, 81(9), 696–704.
  • Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry, 72(1–2), 248–254.
  • Bursać, B.N., et al., 2013. Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue. The journal of nutritional biochemistry, 24(6), 1166–1172.
  • Castelli, W.P., et al., 1983. Summary estimates of cholesterol used to predict coronary heart disease. Circulation, 67(4), 730–734.
  • Chang, H.-C., et al., 2014. Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans. Food and function, 5, 734–739.
  • Dai, J., et al., 2014. Involvement of catalase in the protective benefits of metformin in mice with oxidative liver injury. Chemico-biological interactions, 216(1), 34–42.
  • Day, C.P. and James, O.F.W., 1998. Steatohepatitis: a tale of two “Hits”? Gastroenterology, 114(4), 842–845.
  • Dobiášová, M. and Frohlich, J., 2001. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FER HDL). Clinical biochemistry, 34(7), 583–588.
  • Dongiovanni, P., et al., 2016. Nutritional therapy for nonalcoholic fatty liver disease. The journal of nutritional biochemistry, 29, 1–11.
  • El-Bassossy, H., et al., 2016. Ferulic acid, a natural polyphenol, alleviates insulin resistance and hypertension in fructose fed rats: effect on endothelial-dependent relaxation. Chemico-biological interactions, 254, 191–197.
  • Ellman, G.L., 1959. Tissue sulfhydryl groups. Archives of biochemistry and biophysics, 82(1), 70–77.
  • Esterbauer, H. and Cheeseman, K.H., 1990. [42] Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods in enzymology, 186, 407–421.
  • Evans, J.L., et al., 2003. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes, 52(1), 1–8.
  • Fakhoury-Sayegh, N., et al., 2019. Fructose threshold for inducing organ damage in a rat model of nonalcoholic fatty liver disease. Nutrition research, 62, 101–112.
  • Flohé, L. and Günzler, W.A., 1984. [12] Assays of glutathione peroxidase. Methods in enzymology, 105, 114–120.
  • Fossati, P. and Prencipe, L., 1982. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical chemistry, 28(10), 2077–2080.
  • Friedewald, W.T., et al., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry, 18(6), 499–502.
  • García, M., Godoy, Y.C., and Celuch, S.M., 2013. Impaired hypotensive responses induced by intrathecally injected drugs in fructose-fed rats. European journal of pharmacology, 706(1–3), 17–24.
  • Grove, T.H., 1979. Effect of reagent pH on determination of high-density lipoprotein cholesterol by precipitation with sodium phosphotungstate-magnesium. Clinical chemistry, 25(4), 560–564.
  • Habig, W.H., et al., 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. The journal of biological chemistry, 249(22), 7130–7139.
  • Hamza, N., et al., 2010. Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. Journal of ethnopharmacology, 128(2), 513–518.
  • Hamza, N., et al., 2011. Treatment of high fat diet induced type 2 diabetes in C57BL/6J mice by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. Journal of ethnopharmacology, 133(2), 931–933.
  • Hamza, N., et al., 2015. Effect of Centaurium erythraea Rafn, Artemisia herba-alba Asso and Trigonella foenum-graecum L. on liver fat accumulation in C57BL/6J mice with high-fat diet-induced type 2 diabetes. Journal of ethnopharmacology, 171(1), 4–11.
  • Harlev, E., et al., 2013. Antidiabetic attributes of desert and steppic plants: a review. Planta medica, 79(6), 425–436.
  • Houstis, N., et al., 2006. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 440(7086), 944–948.
  • Houti, L., et al., 2016. Prevalence of metabolic syndrome and its related risk factors in the city of Oran, Algeria: The ISOR study. Ethnicity and disease, 26(1), 99–106.
  • Ibitoye, O.B. and Ajiboye, T.O., 2018. Dietary phenolic acids reverse insulin resistance, hyperglycaemia, dyslipidaemia, inflammation and oxidative stress in high-fructose diet-induced metabolic syndrome rats. Archives of physiology and biochemistry, 124(5), 410–417.
  • Ibrahim, M.A., et al., 2014. Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats. European journal of pharmacology, 724(1), 204–210.
  • Islam, M.N., et al., 2014. Vicenin 2 isolated from Artemisia capillaris exhibited potent anti-glycation properties. Food and chemical toxicology, 69, 55–62.
  • Jiang, L., et al., 2016. Jiangzhi Capsule improves fructose-induced insulin resistance in rats: association with repair of the impaired sarcolemmal glucose transporter-4 recycling. Journal of ethnopharmacology, 194, 288–298.
  • Jollow, D.J., et al., 1974. Bromobenzene-induced liver necrosis. protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology, 11(3), 151–169.
  • Katz, A., et al., 2000. Quantitative insulin sensitivity check index: a simple, accurate method for assessiong insulin sensitivity in humans. The journal of clinical endocrinology and metabolism, 85(7), 2402–2410.
  • Kaur, J., 2014. A comprehensive review on metabolic syndrome. Cardiology research and practice, 2014, 1.
  • Kimura, Y., et al., 1985. Studies on the activities of tannins and related compounds from medicinal plants and drugs. VII. 1) effects of extracts of leaves of Artemisia species, and caffeic acid and chlorogenic acid on lipid metabolic injury in rats fed peroxidized oil. Chemical and pharmaceutical bulletin, 33(5), 2028–2034.,
  • Lim, J.S., et al., 2010. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nature reviews gastroenterology and hepatology, 7(5), 251–264.
  • Liu, L., et al., 2016. Artemisia capillaris formula inhibits hepatic steatosis via an miR-122-induced decrease in fatty acid synthase expression in vivo and in vitro. Molecular medicine reports, 13(6), 4751–4758.,
  • Liu, Z., et al., 2008. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats. Chemico-biological interactions, 173(1), 68–75.
  • Mansi, K., et al., 2007. The hypolipidemic effects of Artemisia sieberi (A. herba-alba) in alloxan induced diabetic rats. International journal of pharmacology, 3(6), 487–491.
  • Marrif, H.I., et al., 1995. Some pharmacological studies on Artemisia herba-alba (Asso.) in rabbits and mice. Journal of ethnopharmacology, 49(1), 51–55.
  • Matthews, D.R., et al., 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412–419.
  • McCracken, E., et al., 2018. Pathophysiology of the metabolic syndrome. Clinics in dermatology, 36(1), 14–20.
  • Nakagawa, T., et al., 2005. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nature clinical practice nephrology, 1(2), 80–86.
  • National Research Council, 2011. Guide for the care and use of laboratory animals. Washington, D.C.: National Academies Press. ISBN-13: 978-0-309-15401-7.
  • Nomura, K., and Yamanouchi, T., 2012. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. The journal of nutritional biochemistry, 23(3), 203–208.
  • Oron-Herman, M., et al., 2008. Metabolic syndrome: Comparison of the two commonly used animal models. American journal of hypertension, 21(9), 1018–1022.
  • Putakala, M., et al., 2017. Beneficial effects of Phyllanthus amarus against high fructose diet induced insulin resistance and hepatic oxidative stress in male wistar rats. Applied biochemistry and biotechnology, 183(3), 744–764.
  • Salido, S., et al., 2004. Composition and infraspecific variability of Artemisia herba-alba from southern Spain. Biochemical systematics and ecology, 32(3), 265–277.,
  • Salman, Z.K., et al., 2013. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats. European journal of pharmacology, 714(1–3), 448–455.
  • Sapin, R., et al., 2001. Elecsys insulin assay: Free insulin determination and the absence of cross-reactivity with insulin lispro. Clinical chemistry, 47(3), 602–605.
  • Sekiou, O., et al., 2018. Mitigating effects of antioxidant properties of Artemisia herba alba aqueous extract on hyperlipidemia and oxidative damage in alloxan-induced diabetic rats. Archives of physiology and biochemistry,125 (2), 163–173.
  • Tappy, L., et al., 2010. Fructose and metabolic diseases: new findings, new questions. Nutrition, 26(11–12), 1044–1049.
  • Tappy, L. and Lê, K.A., 2012. Does fructose consumption contribute to non-alcoholic fatty liver disease? Clinics and research in hepatology and gastroenterology, 36(6), 554–560.
  • Toop, C.R. and Gentili, S., 2016. Fructose beverage consumption induces a metabolic syndrome phenotype in the rat: a systematic review and meta-analysis. Nutrients, 8(9), 577.
  • Trinder, P., 1969. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. Journal of clinical pathology, 22(2), 158–161.
  • Twaij, H.A.A. and Al-Badr, A.A., 1988. Hypoglycemic activity of Artemisia herba alba. Journal of ethnopharmacology, 24(2–3), 123–126.
  • Wang, Z.Q., et al., 2013. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway. Metabolism, 62(9), 1239–1249.
  • Wong, S.K., et al., 2016. Animal models of metabolic syndrome: a review. Nutrition and metabolism, 13(1), 65.
  • Younsi, F., et al., 2016. Essential oil and phenolic compounds of Artemisia herba-alba (Asso.): composition, antioxidant, antiacetylcholinesterase, and antibacterial activities. International journal of food properties, 19(7), 1425–1438.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.